Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer

Journal of Clinical Oncology

Volumn 14, Issue 8, 1996, Pages 2337-2344

  Sculier, J P ^a   Paesmans, M ^a   Bureau, G ^a   Giner, V ^a   Lecomte, J ^a   Michel, J ^a   Berchier, M C ^a   Van Cutsem, O ^a   Kustner U ^a   Kroll, F ^a   Sergysels, R ^a   Mommen, P ^a   Klastersky, J ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; VINDESINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

EID: 9444298439     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.8.2337     Document Type: Article

References (32)

1. Albain KS, Crowley JJ, Livingston RB : Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience. Chest 99:1425-1432, 1991
2. Niiranen A : Long-term survival in small-cell carcinoma of the lung. Eur J Cancer Clin Oncol 24:749-752, 1988
3. Johnson BE, Grayson J, Makuch RW, et al: Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. J Clin Oncol 8:396-401, 1990
4. Livingston RB, Stephens RL, Bonnet JD, et al: Long-term survival and toxicity in small cell lung cancer. Southwest Oncology Group Study. Am J Med 77:415-417, 1984
5. Davis S, Wright PW, Schulman SF, et al: Long-term survival in small cell carcinoma of the lung: A population experience. J Clin Oncol 3:80-91, 1985
6. Choi NC, Carey RW, Kaufman SD, et al: Small cell carcinoma of the lung. A progress report of 15 year's experience. Cancer 51:6-14, 1987
7. Johnson BE, Grayson J, Makuch RW, et al: Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. J Clin Oncol 8:396-401, 1990
8. Feld R, Evans WK, De Boer G: Combined modality induction therapy without maintenance chemotherapy for small-cell carcinoma of the lung. J Clin Oncol 2:294-304, 1984
9. Maurer LH, Tulloh M, Weiss RB: A randomized combined modality trial in small-cell carcinoma of the lung. Comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation. Cancer 45:30-39, 1980
10. Cullen M, Morgan D, Gregory W: Maintenance chemotherapy for anapiastic small-cell carcinoma of the bronchus: A randomized controlled trial. Cancer Chemother Pharmacol 17:157-160, 1986
11. Einhorn LH, Crawford J, Birch R, et al: Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin and vincristine in limited small-cell lung cancer. J Clin Oncol 6:451-456, 1988
12. Johnson DH, Bass D, Einhorn LH, et al: Combination chemotherapy with or without thoracic radiotherapy in limited stage small cell lung cancer: A randomized trial of the Southeastern Cancer Study Group. J Clin Oncol 11:1223-1229, 1993
13. Medical Research Council: Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Br J Cancer 59:584-590, 1989
14. Spiro SG, Souhami RL, Geddes DM, et al: Duration of chemotherapy in small-cell lung cancer: A Cancer Research Campaign trial. Br J Cancer 59:578-583, 1989
15. Byrne MJ, Van Hazel G, Trotter J, et al: Maintenance chemotherapy in limited small-cell lung cancer: A randomized controlled clinical trial. Br J Cancer 60:413-418, 1989
16. Ettinger DS, Finkelstein DM, Abeloff MD, et al: A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive stage small cell lung cancer: A phase III study of the Eastern Cooperative Oncology Group. J Clin Oncol 8:230-240, 1990
17. Mattson K, Niiranen A, Pyrhönen S, et al: Natural interferon alpha as maintenance therapy for small-cell lung cancer. Eur J Cancer 28A:1387-1391, 1992
18. Lebeau B, Chastang CL, Allard P, et al: Six versus twelve cycles for complete responders to chemotherapy in small cell lung cancer: Definitive results of a randomized clinical trial. Eur Respir J 5:286-290, 1992
19. Giaccone G, Dalesio O, McVie GJ, et al: Maintenance chemotherapy in small cell lung cancer: Long-term results of a randomized trial. J Clin Oncol 11:1230-1240 1993
20. Bleehen NM, Girling DJ, Machin D, et al: A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC) I: Survival and prognostic factors. Br J Cancer 68:1150-1156, 1993
21. Sculier JP, Bureau G, Giner V, et al: Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: Experience of the European Lung Cancer Working Party. Semin Oncol 22:18-22, 1995 (suppl 2)
22. Sculier JP, Paesmans M, Bureau G, et al: Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: A phase III randomized study conducted by the European Lung Cancer Working Party. J Clin Oncol 11:1858-1865, 1993
23. Freedman LS, White SJ: On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics 32:691-694, 1976
24. Plosker GL, Faulds D: Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy. Drugs 45:788-856, 1993
25. Sculier JP, Klastersky J, Libert P, et al: A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. Ann Oncol 1:128-133, 1990
26. Natale RB, Gralla RJ, Wittes RE: Phase II trial of vindesine in patients with small cell lung carcinoma. Cancer Treat Rep 65:129-131, 1981
27. Osterlind K, Dombernowsky P, Sorensen PG, et al: Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma. Cancer Treat Rep 65:245-248; 1981
28. Morgan DAL: Efficacy and tolerabiiity of vindesine in the treatment of small-cell lung cancer. Cancer Chemother Pharmacol 18:172-173, 1986
29. Bunn PA Jr, Cullen M, Fukuoka M, et al: Chemotherapy in small cell lung cancer: A consensus report, in Hansen HH, PEG Kristjansen (eds): Managament of Small Cell Lung Cancer. Third IASLC Workshop on Small Lung Cancer. Elsinore, Denmark, June 18-22, 1989. Amsterdam, the Netherlands, Elsevier, 1989, pp 9-16
30. Allan SG, Gregor A, Cornbleet MA, et al: Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer. Cancer Chemother Pharmacol 13:106-108, 1984
31. Warde P, Payne D: Does thoracic irradiation improve survival and local control in limited stage small cell lung carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890-895, 1992
32. Pignon JP, Arriagada R, Ihde DC, et al: A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 327:1618-1624, 1992